Results

Total Results: 1,571 records

Showing results for "discussed".

41. Research White Paper_Outcome Measure Harmonization and Data Infrastructure for Patient-Centered Outcomes Research in Depression: Data Use and Governance Toolkit (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/outcomes-research-depression.pdf
    October 01, 2021 - This may also include information about the registry data as discussed above. … Governance structure is discussed further in Section 2 of this chapter. … The governance procedures required for this process are discussed in Section 3 of this chapter. … The governance procedures required for this process are discussed in Section 3 of this chapter. … These issues are discussed further in Section 6 of this Chapter.

42. nnovative Methods in Stakeholder Engagement: An Environmental Scan (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_research-2012-1.pdf
    January 01, 2012 - The remaining Web sites discussed stakeholder engagement in the United Kingdom, Canada, and Europe … Use of technology is discussed within each of these points. … Policy concerns identified by the key informants were discussed at a workshop with a subset of the … Idea generation tools are often discussed in the context of innovation. … Another key informant discussed the value of social media marketing through creating viral messages

43. Meeting Summary (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_slides-2011.pdf
    January 01, 2011 - Other approaches discussed for recruiting patient/ consumer representatives from underrepresented populations … In addition to training activities, panelists discussed other ways in which researchers can support … Finally, panelists discussed the goal of getting beyond just distribution and dissemination of research

44. Research White Paper Managing Missing Data in Patient Registries Addendum Registries for Evaluating Patient Outcomes Third Edition (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/missing-data-registries-guide-3rd-ed-addendum-white-paper.pdf
    February 01, 2018 - These concepts are discussed in the context of internal validity of studies, or the ability to draw … Strategies to retain participants and minimize loss to followup are discussed extensively in Chapters … The processes for integrating secondary data sources with a patient registry are discussed elsewhere … As discussed in Chapter 11 of the User’s Guide, a 6 Managing Missing Data in Patient Registries … As discussed previously, missing data can be categorized as MCAR, MAR, or MNAR.

45. Disposition of Comments for Management of Suspected Opioid Overdose With Naloxone by Emergency Medical Services Personnel (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-disposition-comments-naloxone.pdf
    November 27, 2017 - The issue of illicit fentanyl and fentanyl analogues and how they may impact dosing is discussed … Meaning, it should be clearly discussed that with the high potency opioids in our country today, that … The issue of illicit fentanyl and how it may affect dosing is discussed in several places in the … The detail about the proportion of overdoses related to use of opium is discussed in the Results of … However, in the population being discussed here with the routine EMS use, I feel this is reasonably

46. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atrial-fibrillation-ablation_disposition-comments.pdf
    October 01, 2010 - should be placed in Table 1 rather than Table 2 or alternatively, methodological quality should be discussed … of monitoring, inconsistent treatment of repeat procedures and use of medications were not always discussed … Two of these were not studies of pulmonary vein isolation and will not be discussed further.(2,3) Two … of the remaining 7 studies examined QoL specifically in patients with heart failure as discussed previously … one was a study included in the assessment of safety outcomes (key question 4) but not otherwise discussed

47. Santa_ECCS2012 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/santa_eccs2012.pdf
    February 01, 2013 - • 9 percent  had discussed the accuracy of the test. … • 1 percent had  discussed  with  their  physician  whether  or not the  test saved

48. Treating and Preventing C. difficile Infections (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/c-difficile-update_consumer.pdf
    May 01, 2017 - Things you can do to help prevent CDI are discussed on page 8 of this summary. 3 Archived: This … These treatments are discussed in more detail in the pages that follow.

49. Disposition of Comments for Technical Brief 23 Genetic Testing (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/genetic-testing-developmental-disabilities_disposition-comments.pdf
    June 30, 2015 - The DD condition discussed in the reviewer’s example is beyond the scope of work. … The small number of clinical validity studies are discussed in body text. … We had discussed these challenges in the previous draft. … We also discussed what kind of future studies are needed to fill the gaps. … In the report, we have discussed potential limitations of the GTR database.

50. Future Research Needs for Diagnosis of Obstructive Sleep Apnea (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-diagnosis-future_research.pdf
    February 01, 2012 - Fourteen other future research needs topics were discussed. Challenges. … However, as discussed by the stakeholders, it may be challenging to gather all the relevant data. … One Web site was created for the diagnosis topics discussed in this document and a separate Web site … The effectiveness of perioperative care was discussed as well as strategies for mitigating risks such … However, as discussed by the stakeholders, it may be challenging to gather all the relevant data.

51. Evaluation of Mental Health Applications (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/mental-health-app-protocol-updated.pdf
    January 01, 2018 - For each abstracted domain, the relevance to this project will be discussed and determined among the … reviewers will be assessed and any discrepancies in the application of the framework will be recorded, discussed … reviewers will be assessed and any discrepancies in the application of the framework will be recorded, discussed

52. Disposition of Comments for CER 225: Substance Abuse Disorders in Adolescents (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/cer-225-substance-abuse-adolescents-comments.pdf
    May 21, 2020 - Discrepant codes were discussed, and if needed, reviewed by a 3rd coder.

53. Effectiveness of Early Diagnosis, Prevention, and Treatment of Clostridium difficile Infection (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections_disposition-comments.pdf
    March 01, 2012 - This statement as discussed above is not coherent with the guidelines proposed by the SHEA/IDSA statements … Both the Planche and Bricker reviews were discussed, but only the articles which met inclusion criteria … Reference tests are discussed on page 39, lines 9 to15 and page 89, last sentence of the penultimate … The blinding is discussed on page 39, line 16- 20 in the section on quality of studies and is summarized … As discussed above, only 2 of 10 studies used treatment duration < 10 days, and one did not report

54. Screening and Diagnosing Gestational Diabetes Mellitus Disposition of Comments Report (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/gestational-diabetes-screening-diagnosis_disposition-comments.pdf
    January 01, 2020 - Peer Reviewer #3 General – Clarity & Usability As discussed above I believe the discussion is … report) and especially the post-hoc decision to include shoulder dystocia and macrosomia should be discussed … is stated but the reason for not including case control studies (although understandable) is not discussed … This should be further discussed in the limitations. … We have discussed induction of labor and cesarean section under Key Question 5 as well as Key Question

55. Long-Term Care for Older Adults Disposition of Comments Report (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/long-term-care-adults_disposition-comments.pdf
    November 07, 2012 - community-based services, of which state plan personal care is by far the most important and should be discussed … We have discussed the challenges/limitations of the study in the Discussion section. … Reviewer #8 Methods Direct and indirect costs discussed on p. 5 need to be more clearly defined. … Reviewer #8 Methods Although moderating variables are discussed on p. 5, I don't believe these are carried … There were many limitations to this study which they discussed.

56. Disposition of Comments_Technical Brief 52: Pediatric Quality Measures Program 3.0: An Evidence Map of Measures for Vision, Hearing, and Developmental Screening and Followup (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/pqmp-disposition-comments.pdf
    April 07, 2025 - The interventions of chart-based and instrument-based screenings were discussed thoroughly, and age-based … I was impressed to see that on page 178/186, family support resources by state were discussed, as … Page 180/188 discussed the need for further comparison of evaluation techniques in order for a more … The mixed results for feasibility were discussed in 4.2, 6th paragraph. … The steps are directly linked to the gaps and issues discussed in previous sections, providing a clear

57. Ch 5-User-Guide-To-Ocer 130129 (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/ch_5-user-guide-to-ocer_130129.pdf
    January 01, 2012 - Misclassification Misclassification is one of the major threats to validity in observational CER studies and is discussed … important considerations regarding the definition, measurement, and operationalization of exposure are discussed … Indication As discussed, the overriding consideration that should guide comparator choice is the generation … person- time has to be avoided for both the exposure and comparison group.6 Exposure Time Window As discussed … Comparisons Across Different Treatment Modalities Many principles in the previous sections are discussed

58. EPC-Pilot-Project-A-Dual-Approach-To-Facilitate-Health-Systems-Uptake-Of-Evidence-Synthesis-Reports-Anxiety-In-Children (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-anxiety-children_0.pdf
    October 01, 2018 - Patients and parents prioritized the cards and chose the order in which these issues were discussed … In collaboration with two psychologists, the 5 topics usually discussed when a treatment is chosen … The respective card will be discussed first. … Crosse, WI, mentioned that the state of Wisconsin requires that information on the down sides of CBT be discussed

59. Registry of Patient Registries (RoPR): Project Overview (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/registry-of-patient-registries_research-2012-3_0.pdf
    January 01, 2012 - These options were discussed among stakeholders, the Agency for Healthcare Research and Quality (AHRQ … The following project constraints were discussed as part of these considerations: • Stakeholder input—as

60. Disposition of Comments_Systematic Review: Breastfeeding and Health Outcomes for Infants and Children (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/related_files/breastfeeding-health-outcomes-disposition-comments.pdf
    March 31, 2025 - not add a statement of causality in the abstract, but this and the need for additional research is discussed … The inclusion of autism spectrum disorder as an outcome of interest was discussed by the review authors … Iron deficiency and iron deficiency anemia were discussed as potential outcomes to include in the review … The inclusion of ADHD and autism spectrum disorder as outcomes of interest were discussed by the review … Discrepancies in the extracted data were discussed and resolved.”